Fig. 2: AEA measurements and 95% CI over time in the groups; IM administration, IV administration, </≥16 years and inactivation. | Leukemia

Fig. 2: AEA measurements and 95% CI over time in the groups; IM administration, IV administration, </≥16 years and inactivation.

From: Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia

Fig. 2

AEA measurements day 1,4,7 and 11 after first dose and AEA Ctrough after every dose of peg-asparaginase. Patients with inactivation are illustrated as the blue line (including one patient with IM administered PEG-asparaginase and three patients ≥16 years) and patients in the non-inactivation group as the red, black and green line according to route of administration and age group.

Back to article page